Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cancers|March 25, 2022
The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted TherapiesMaria J De Herdt, Berdine van der Steen, Robert J Baatenburg de Jong, et al.BMC Cancer|June 12, 2008
Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: a pathway-based analysisErik F Hensen, Maria J De Herdt, Jelle J Goeman, et al.Cancers|September 9, 2022
Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer PatientsChumut Phanthunane, Rebecca Wijers, Maria J De Herdt, et al.Oncotarget|April 23, 2016
MET expression during prostate cancer progressionEsther I Verhoef, Kimberley Kolijn, Maria J De Herdt, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinomaMaria J De Herdt, Senada Koljenović, Berdine van der Steen, et al.Frontiers in Oncology|May 17, 2021
The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell CarcinomaMaria J De Herdt, Berdine van der Steen, Quincy M van der Toom, et al.Human Pathology|July 24, 2020
A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding, and loss of E-cadherin with poor prognosis in oral squamous cell carcinomaMaria J De Herdt, Senada Koljenović, Berdine van der Steen, et al.Oncotarget|February 25, 2016
Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinomaMaria J De Herdt, Stefan M Willems, Berdine van der Steen, et al.BMC Cancer|April 25, 2025
Rotterdam Oncology Documentation (RONCDOC) - a high-quality data warehouse and tissue collection for head and neck cancerArta Hoesseini, Emilie A C Dronkers, Eveline Dieleman, et al.Annals of Diagnostic Pathology|February 12, 2022
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanomaEvalyn E A P Mulder, Daniëlle Verver, Thom van der Klok, et al.Pageof 2